FBIO Fortress Biotech, Inc.
Nasdaq · SEC CIK 1429260 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 75 since 2022-04-29, latest 2026-06-24 21:50
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jin David | CFO | — | — |
| Lorenz Kevin | Dir | — | — |
| Klein Dov | Dir | — | — |
| Harvey Jimmie | Dir | — | — |
| Hoenlein Malcolm | Dir | — | — |
| LOBELL J JAY | Dir | — | — |
| WEISS MICHAEL S | Executive Vice COB, Dir | — | — |
| ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | — | — |
Transactions 79
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-24 21:50 | 2026-06-22 | FBIO | Jin David | CFO | A - Grant | $0.00 | +400.0K | 1.65M | +32% | $0 | |
| 2026-04-01 16:05 | 2026-04-01 | FBIO | Jin David | CFO | A - Grant | $2.18 | +2,967 | 1.25M | +0.2% | +$6,456 | |
| 2026-03-20 | 2026-03-18 | FBIO | WEISS MICHAEL S | Executive Vice COB, Dir | A - Grant | $0.00 | +475.4K | 2.28M | +26% | $0 | |
| 2026-03-20 | 2026-03-18 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | A - Grant | $0.00 | +475.4K | 4.59M | +12% | $0 | |
| 2026-01-05 | 2026-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +27.3K | 101.0K | +37% | $0 | |
| 2026-01-05 | 2026-01-01 | FBIO | Hoenlein Malcolm | Dir | A - Grant | $0.00 | +27.3K | 115.7K | +31% | $0 | |
| 2026-01-05 | 2026-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +27.3K | 192.4K | +17% | $0 | |
| 2026-01-05 | 2026-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +27.3K | 130.1K | +27% | $0 | |
| 2026-01-05 | 2026-01-01 | FBIO | Harvey Jimmie | Dir | A - Grant | $0.00 | +27.3K | 146.7K | +23% | $0 | |
| 2025-10-02 | 2025-10-01 | FBIO | Jin David | CFO | A - Grant | $1.31 | +2,711 | 1.25M | +0.2% | +$3,551 | |
| 2025-04-01 | 2025-04-01 | FBIO | Jin David | CFO | A - Grant | $1.22 | +5,000 | 1.25M | +0.4% | +$6,100 | |
| 2025-01-03 | 2025-01-01 | FBIO | Lu Lucy | Dir | A - Grant | $0.00 | +49.4K | 61.3K | +415% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +49.4K | 73.7K | +203% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | WEISS MICHAEL S | Executive Vice COB, Dir | A - Grant | $0.00 | +454.2K | 1.80M | +34% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | Harvey Jimmie | Dir | A - Grant | $0.00 | +49.4K | 119.4K | +71% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | Hoenlein Malcolm | Dir | A - Grant | $0.00 | +49.4K | 88.4K | +126% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +49.4K | 102.8K | +92% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +49.4K | 165.1K | +43% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | A - Grant | $0.00 | +454.2K | 4.11M | +12% | $0 | |
| 2024-12-23 | 2024-12-19 | FBIO | Jin David | CFO | A - Grant | $0.00 | +1.00M | 1.24M | +415% | $0 | |
| 2024-10-01 | 2024-10-01 | FBIO | Jin David | CFO | A - Grant | $1.23 | +2,625 | 240.9K | +1% | +$3,229 | |
| D | 2024-09-25 | 2024-09-23 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.84 | +763.4K | 3.66M | +26% | +$1.40M |
| 2024-07-15 | 2024-07-11 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $7.48 | +5,000 | 127.5K | +4% | +$37.4K | |
| 2024-07-12 | 2024-07-10 | FBIO | Jin David | CFO | P - Purchase | $7.50 | +500 | 500 | New | +$3,750 | |
| 2024-07-11 | 2024-07-09 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $7.39 | +5,000 | 122.5K | +4% | +$37.0K | |
| 2024-07-10 | 2024-07-08 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $7.35 | +5,000 | 117.5K | +4% | +$36.8K | |
| 2024-07-01 | 2024-06-28 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.64 | +20.0K | 2.89M | +0.7% | +$32.8K | |
| 2024-05-20 | 2024-05-16 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.76 | +10.0K | 2.87M | +0.3% | +$17.6K | |
| 2024-05-20 | 2024-05-20 | FBIO | Klein Dov | Dir | S - Sale | $1.89 | -10.0K | 53.4K | -16% | -$18.9K | |
| 2024-04-02 | 2024-04-01 | FBIO | Jin David | CFO | A - Grant | $1.70 | +2,352 | 238.3K | +1.0% | +$3,998 | |
| 2024-01-09 | 2024-01-05 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $2.38 | +50.0K | 2.86M | +2% | +$119.0K | |
| 2024-01-03 | 2024-01-01 | FBIO | Harvey Jimmie | Dir | A - Grant | $0.00 | +6,666 | 70.0K | +11% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | A - Grant | $0.00 | +216.5K | 2.81M | +8% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +3,333 | 24.3K | +16% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Rowinsky Eric K | Dir | A - Grant | $0.00 | +6,666 | 68.8K | +11% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | WEISS MICHAEL S | See Remarks, Dir, 10% | A - Grant | $0.00 | +216.5K | 1.35M | +19% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +6,666 | 115.7K | +6% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Hoenlein Malcolm | Dir | A - Grant | $0.00 | +3,333 | 39.0K | +9% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +6,666 | 63.4K | +12% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Lu Lucy | Dir | A - Grant | $0.00 | +3,333 | 11.9K | +39% | $0 | |
| 2023-12-22 | 2023-12-20 | FBIO | Jin David | CFO | A - Grant | $0.00 | +140.0K | 235.9K | +146% | $0 | |
| D | 2023-11-16 | 2023-11-14 | FBIO | WEISS MICHAEL S | See Remarks, Dir | P - Purchase | $1.70 | +147.1K | 1.13M | +15% | +$250.0K |
| D | 2023-11-16 | 2023-11-14 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.70 | +1.57M | 2.60M | +152% | +$2.66M |
| 2023-09-27 | 2023-09-26 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.28 | +100.0K | 15.45M | +0.7% | +$28.0K | |
| M | 2023-08-21 | 2023-08-17+ | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $10.54 | +20.0K | 112.5K | +22% | +$210.9K |
| 2023-02-14 | 2023-02-10 | FBIO | Lu Lucy | Dir | P - Purchase | $0.84 | +12.0K | 133.4K | +10% | +$10.1K | |
| 2023-02-14 | 2023-02-10 | FBIO | Rowinsky Eric K | Dir | P - Purchase | $0.84 | +12.0K | 932.0K | +1% | +$10.1K | |
| 2023-02-14 | 2023-02-10 | FBIO | LOBELL J JAY | Dir | P - Purchase | $0.84 | +299.4K | 1.64M | +22% | +$251.5K | |
| 2023-02-14 | 2023-02-10 | FBIO | Jin David | CFO | P - Purchase | $0.84 | +35.9K | 1.44M | +3% | +$30.2K | |
| 2023-02-14 | 2023-02-10 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.84 | +2.40M | 15.35M | +18% | +$2.01M | |
| 2023-02-14 | 2023-02-10 | FBIO | WEISS MICHAEL S | See Remarks, Dir, 10% | P - Purchase | $0.84 | +1.20M | 14.75M | +9% | +$1.01M | |
| 2023-01-04 | 2023-01-01 | FBIO | Rowinsky Eric K | Dir | A - Grant | $0.00 | +100.0K | 920.0K | +12% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | WEISS MICHAEL S | See Remarks, Dir, 10% | A - Grant | $0.00 | +1.22M | 13.55M | +10% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | Hoenlein Malcolm | Dir | A - Grant | $0.00 | +50.0K | 535.6K | +10% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | Harvey Jimmie | Dir | A - Grant | $0.00 | +100.0K | 950.0K | +12% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | Lu Lucy | Dir | A - Grant | $0.00 | +50.0K | 121.4K | +70% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +100.0K | 1.34M | +8% | $0 | |
| 2023-01-04 | 2023-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +50.0K | 314.6K | +19% | $0 | |
| M | 2023-01-04 | 2022-06-01+ | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | A - Grant | $0.0025 | +1.22M | 11.73M | +12% | +$3,113 |
| 2023-01-04 | 2023-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +100.0K | 851.0K | +13% | $0 | |
| 2022-12-19 | 2022-12-16 | FBIO | Lu Lucy | Dir | A - Grant | $0.00 | +30.0K | 71.4K | +72% | $0 | |
| 2022-12-05 | 2022-12-01 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.68 | +100.0K | 11.73M | +0.9% | +$68.0K | |
| 2022-12-02 | 2022-11-30 | FBIO | Jin David | CFO | P - Purchase | $0.56 | +5,000 | 1.40M | +0.4% | +$2,800 | |
| 2022-12-02 | 2022-11-30 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.56 | +5,000 | 11.63M | +0.0% | +$2,800 | |
| 2022-10-28 | 2022-10-26 | FBIO | Jin David | CFO | A - Grant | $0.00 | +1.35M | 1.40M | +2,823% | $0 | |
| 2022-10-24 | 2022-10-21 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $0.7 | +100.0K | 11.63M | +0.9% | +$70.0K | |
| M | 2022-04-29 | 2021-09-30+ | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | J - Other | $0.00 | +12.8K | 10.42M | +0.1% | $0 |
| M | 2022-04-29 | 2021-06-01+ | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | A - Grant | $0.0054 | +1.11M | 10.41M | +12% | +$6,021 |
| 2022-04-29 | 2022-01-01 | FBIO | Rowinsky Eric K | Dir | A - Grant | $0.00 | +100.0K | 820.0K | +14% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | Harvey Jimmie | Dir | A - Grant | $0.00 | +100.0K | 850.0K | +13% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | WEISS MICHAEL S | See Remarks, Dir, 10% | A - Grant | $0.00 | +1.10M | 12.34M | +10% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | LOBELL J JAY | Dir | A - Grant | $0.00 | +100.0K | 1.24M | +9% | $0 | |
| M | 2022-04-29 | 2021-08-05+ | FBIO | Klein Dov | Dir | J - Other | $0.00 | +1,015 | 655.8K | +0.2% | $0 |
| 2022-04-29 | 2021-12-28 | FBIO | Klein Dov | Dir | S - Sale | $2.45 | -5,000 | 651.0K | -0.8% | -$12.2K | |
| 2022-04-29 | 2022-01-01 | FBIO | Klein Dov | Dir | A - Grant | $0.00 | +100.0K | 751.0K | +15% | $0 | |
| 2022-04-29 | 2021-09-21 | FBIO | Hunter Robyn | CFO | S - Sale | $3.13 | -28.3K | 163.9K | -15% | -$88.6K | |
| M | 2022-04-29 | 2021-09-30+ | FBIO | Hoenlein Malcolm | Dir | J - Other | $0.00 | +636 | 435.4K | +0.1% | $0 |
| 2022-04-29 | 2022-01-01 | FBIO | Hoenlein Malcolm | Dir | A - Grant | $0.00 | +50.0K | 485.6K | +11% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +50.0K | 264.6K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations